BIOCON Financial Statements

Biocon Profit & Loss Statement

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 11.60 54.40 5.97 16.20
Op profit growth 3.09 93.40 (15) 27.60
EBIT growth (1.70) 80.50 (22) 43.60
Net profit growth (1) 101 (39) 11.20
Profitability ratios (%)        
OPM 23.30 25.20 20.10 25.20
EBIT margin 16.80 19 16.30 22.10
Net profit margin 10.40 11.80 9.03 15.70
RoCE 10.30 13.40 8.60 11.90
RoNW 2.58 3.15 1.86 3.45
RoA 1.60 2.06 1.19 2.12
Per share ratios ()        
EPS 7.05 7.26 7.55 34.40
Dividend per share -- -- 1 3
Cash EPS 0.21 1.63 (0.20) 16.70
Book value per share 63.60 55.90 86.30 242
Valuation ratios        
P/E 58 37.30 39.40 5.49
P/CEPS 1,931 166 (1,404) 11.30
P/B 6.43 4.84 3.44 0.78
EV/EBIDTA 27 19.40 34.60 21.10
Payout (%)        
Dividend payout -- -- 16.10 9.80
Tax payout (20) (27) (26) (19)
Liquidity ratios        
Debtor days 62.70 65.60 86.20 74.90
Inventory days 84.80 61.90 60.10 55.20
Creditor days (122) (114) (120) (110)
Leverage ratios        
Interest coverage (21) (19) (11) (33)
Net debt / equity 0.32 0.26 0.18 0.26
Net debt / op. profit 1.49 1.07 1.14 1.28
Cost breakup ()        
Material costs (31) (32) (40) (37)
Employee costs (25) (23) (23) (19)
Other costs (21) (20) (18) (18)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 7,106 6,367 4,123 3,891
yoy growth (%) 11.60 54.40 5.97 16.20
Raw materials (2,209) (2,052) (1,636) (1,447)
As % of sales 31.10 32.20 39.70 37.20
Employee costs (1,741) (1,459) (931) (747)
As % of sales 24.50 22.90 22.60 19.20
Other costs (1,504) (1,253) (727) (718)
As % of sales 21.20 19.70 17.60 18.50
Operating profit 1,653 1,603 829 980
OPM 23.30 25.20 20.10 25.20
Depreciation (715) (552) (385) (277)
Interest expense (58) (65) (62) (26)
Other income 255 161 228 157
Profit before tax 1,134 1,147 610 833
Taxes (222) (315) (157) (162)
Tax rate (20) (27) (26) (19)
Minorities and other (115) (123) (81) (76)
Adj. profit 797 710 372 596
Exceptional items 12.60 67.50 -- --
Net profit 741 748 372 612
yoy growth (%) (1) 101 (39) 11.20
NPM 10.40 11.80 9.03 15.70
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Profit before tax 1,134 1,147 610 833
Depreciation (715) (552) (385) (277)
Tax paid (222) (315) (157) (162)
Working capital 2,894 1,038 1,054 374
Other operating items -- -- -- --
Operating cashflow 3,092 1,318 1,122 768
Capital expenditure 8,155 6,658 3,164 2,389
Free cash flow 11,247 7,977 4,286 3,157
Equity raised 8,959 8,452 7,695 7,356
Investments 1,396 380 (90) 1,023
Debt financing/disposal 4,581 2,665 1,614 1,758
Dividends paid -- -- 60 60
Other items -- -- -- --
Net in cash 26,182 19,474 13,565 13,354
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 600 600 300 300
Preference capital -- -- -- --
Reserves 7,027 6,106 5,798 4,881
Net worth 7,627 6,706 6,098 5,181
Minority interest
Debt 4,481 2,715 2,422 2,264
Deferred tax liabilities (net) 32.30 29.80 233 103
Total liabilities 13,021 10,128 9,362 8,015
Fixed assets 9,164 8,167 6,370 5,002
Intangible assets
Investments 1,952 966 1,012 675
Deferred tax asset (net) 308 368 558 296
Net working capital (418) (372) 365 719
Inventories 1,867 1,436 1,032 723
Inventory Days 95.90 82.30 -- 64
Sundry debtors 1,218 1,224 1,292 1,064
Debtor days 62.50 70.10 -- 94.20
Other current assets 1,999 1,284 1,105 1,010
Sundry creditors (1,864) (1,778) (1,521) (1,198)
Creditor days 95.70 102 -- 106
Other current liabilities (3,638) (2,538) (1,543) (879)
Cash 2,015 999 1,057 1,323
Total assets 13,021 10,128 9,362 8,015
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Dec-2021 Sep-2021 Jun-2021 Mar-2021 Dec-2020
Gross Sales 2,174 1,840 1,761 1,842 1,857
Excise Duty -- -- -- -- --
Net Sales 2,174 1,840 1,761 1,842 1,857
Other Operating Income -- -- -- -- --
Other Income 48.30 105 47.20 218 27.90
Total Income 2,223 1,945 1,808 2,060 1,885
Total Expenditure ** 1,733 1,515 1,427 1,476 1,459
PBIDT 489 430 380 584 427
Interest 14.70 22.50 19.90 33.90 4.80
PBDT 475 408 361 550 422
Depreciation 206 202 195 184 186
Minority Interest Before NP -- -- -- -- --
Tax 49.30 46.30 57.30 69.40 48.90
Deferred Tax -- -- -- -- --
Reported Profit After Tax 220 160 108 296 187
Minority Interest After NP 32.50 21.40 24 43.20 18
Net Profit after Minority Interest 187 138 84.40 253 169
Extra-ordinary Items -- (54) -- 10.20 --
Adjusted Profit After Extra-ordinary item 187 193 84.40 243 169
EPS (Unit Curr.) 1.57 1.16 0.71 2.13 1.42
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 600 600 600 600 600
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 22.50 23.40 21.60 31.70 23
PBDTM(%) 21.80 22.10 20.50 29.90 22.70
PATM(%) 10.10 8.68 6.16 16.10 10
Open ZERO Brokerage Demat Account
Open ZERO Brokerage Demat Account

  • 0

    Delivery Brokerage for Lifetime

  • 20

    Per order for Intraday, F&O, Currency & Commodity